Tech Company Financing Transactions
Metabolix Funding Round
Metabolix secured a $17.5 million financing round on 3/31/2006. Investors included The Vertical Group.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$17,520,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
21 Erie St. 100
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Metabolix (NASDAQ: MBLX) applies the cutting edge tools of biotechnology to create a new generation of highly versatile, sustainable, biobased, biodegradable, natural plastics and chemicals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Shaulson
Chief Scientific Officer
Oliver Peoples
VP - Bus. Development
Max Senechal
VP - General Counsel
Sarah Cecil
VP - Manufacturing
Lynne Brum
VP - Manufacturing
Johan Walsem
Browse more venture capital transactions:
Prev: 3/31/2006: Nexsan Technologies venture capital transaction
Next: 3/31/2006: CFD Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs